Bristol Myers Squibb is a pharmaceutical company that develops and sells branded prescription medicines. It last closed at $61.38 on Nov 17, down 2.46% on the day. BMY reports earnings on Thu, Feb 4, 2027. The average 12-month price target from 5 analysts is $59.00 (-3.9% from the last close), with a high of $78.00 and a low of $40.00. Analyst consensus is Hold, based on the latest ratings from 5 firms (1 buy, 3 hold, 1 sell). Over the past 90 days StreetAlpha recorded 2 whale options trades in BMY, 50% of them bullish and 50% bearish. In the past 30 days there were 10 dark pool prints totaling $35.6M, the largest $25.9M.
Each firm's latest rating on BMY in the past 90 days
Average 12-month target
$59.00
▼ 3.9% downside
Based on 5 analysts who set a price target on BMY in the past 90 days. The average target is $59.00, with a high of $78.00 and a low of $40.00, compared with the last close of $61.38.
Highest target$78.00
Average target$59.00
Lowest target$40.00
Latest rating changes
Morgan StanleyTarget lowered
Oct 30Sell$41 → $40
Piper SandlerTarget lowered
Oct 26Buy$82 → $78
Cantor FitzgeraldTarget lowered
Oct 8Hold$59 → $53
Morgan StanleyMaintained
Oct 7Sell$41
Leerink PartnersDowngrade
Oct 5Hold$59
Date
Firm
Action
Rating
Price target
Oct 30
Morgan Stanley
Target lowered
Sell
$41 → $40
Oct 26
Piper Sandler
Target lowered
Buy
$82 → $78
Oct 8
Cantor Fitzgerald
Target lowered
Hold
$59 → $53
Oct 7
Morgan Stanley
Maintained
Sell
$41
Oct 5
Leerink Partners
Downgrade
Hold
$59
Loading…
Technical Analysis
BMY · as of the Nov 17 close · updated after every close
Moving sideways
The stock is 1% below its 20 day and 1% below its 50 day average. It is 2% above its 200 day average, so the longer trend is still up. Momentum is fading (RSI 47). The nearest support is the swing low (Nov 10) at $61.30, and the nearest resistance the 50 day average at $61.75.
Short trendNeutral
Long trendBullish
MomentumFading
StretchNormal
VolatilityHigh, 3.0%/day
Key levels
$68.6452 week high+11.8%
$62.40100 day average+1.7%
$62.2620 day average+1.4%
$62.25Swing high (Oct 15)+1.4%
$62.12Pivot R1+1.2%
$61.7550 day average+0.6%
$61.38Pivot+0.0%
$61.38Last close
$61.30Swing low (Nov 10)−0.1%
$60.64Pivot S1−1.2%
$60.41200 day average−1.6%
$45.2752 week low−26.2%
Indicators
RSI (14)
47.08
Middle of its range
Neutral
MACD
0.30
Below its signal line
Bearish
Stochastic
46.6
Middle of its range
Neutral
ADX (14)
14.6
No clear trend
Williams %R
-75.1
Oversold below −80, overbought above −20
Neutral
CCI (20)
-85.1
Oversold below −100, overbought above 100
Neutral
Rate of change
−0.5%
Change over 10 sessions
Bearish
ATR (14)
$1.83
Typical daily range, 3.0% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Above
Rising
Short trendBullish
Long trendNot enough history
MomentumFading
StretchNormal
VolatilityNormal, 5.9%/day
Key levels
$68.6452 week high+11.8%
$62.40100 day average+1.7%
$62.2620 day average+1.4%
$62.25Swing high (Oct 15)+1.4%
$62.12Pivot R1+1.2%
$61.7550 day average+0.6%
$61.38Pivot+0.0%
$61.38Last close
$61.30Swing low (Nov 10)−0.1%
$60.64Pivot S1−1.2%
$60.41200 day average−1.6%
$45.2752 week low−26.2%
Indicators
RSI (14)
50.54
Middle of its range
Neutral
MACD
0.80
Below its signal line
Bearish
Stochastic
49.4
Middle of its range
Neutral
ADX (14)
20.8
Weak trend
Williams %R
-58.1
Oversold below −80, overbought above −20
Neutral
CCI (20)
-14.4
Oversold below −100, overbought above 100
Neutral
Rate of change
−3.5%
Change over 10 sessions
Bearish
ATR (14)
$3.60
Typical daily range, 5.9% of price
MA 10Below
MA 20Below
MA 50Above
MA 100Above
MA 200–
What happened before, for BMY
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
What happened before
See how BMY did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record.
November seasonalityHow BMY usually does this month. See Seasonality
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
Seasonality
How BMY has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2006.
For membersMonth by month buying, shares and the average price paid each month are shown to AI Starter and AI Pro members.
From the company's 10-Q filed Oct 29, 2026. Quarters are the company's own fiscal quarters. Yield and % of value use the latest close. Buybacks are not a forecast: in our testing, the biggest buyers did about the same as the average S&P 500 stock.
AI Auto Pilots
Paper trading
StreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether BMY is in one of them and how their past BMY trades turned out.
Members of Congress and senior officials report trades up to 45 days later, as dollar ranges. Filings show a trade happened, not why. Not investment advice.
About Bristol Myers Squibb
Bristol Myers Squibb is a pharmaceutical company based in Princeton, New Jersey. It develops, produces and sells branded prescription medicines, including Eliquis, Opdivo and Orencia, and it continues to research new drugs. Its products are paid for through government programs and commercial insurance plans, so pricing and coverage rules affect its sales.